Sains Malaysiana 51(4)(2022): 1181-1196

http://doi.org/10.17576/jsm-2022-5104-19

Dehydroabietic Acid Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice and VCAM-1 Expressions in-vitro

(Asid Dehidroabietik Melemahkan Aterosklerosis dalam Tikus Apolipoprotein E-Kurang dan Pengekspresan VCAM-1 in-vitro)

XIAO LIANG & YAN WU^*

Department of General Medicine, The First People's Hospital of Lianyungang, Lianyungang, Jiangsu, China, 222000

Diserahkan: 21 Julai 2021/Diterima: 30 Ogos 2021

Abstract

Dehydroabietic acid (DHA) is an analog of abietic acid (AA) for cardiovascular disease prevention, known to act pharmacologically against aging, inflammation, bacterial infections and cancer. The current research investigated the molecular mechanisms of DHA on the adhesiveness of endothelial leukocytes and activation of NF-κB in TNF-α treated HAEC and ApoE−/− mice in experimental atherosclerosis. The HAECs were tested for toxicity using MTT assay at various DHA concentrations. The cell-surface expression of CAM against endothelial leukocyte adhesion molecule-1, ICAM -1, or human VCAM-1 was determined by the ELISA test, followed by western blot analysis. Endothelial cell-leukocyte adhesion assay involving U937 cells was carried out followed by the determination of NF-κB p65 expression. ApoE−/− mice were fed with a high cholesterol diet every day followed by oral administration of DHA (10 and 20 mg/kg/day). The DHA (5 and 10 mM) substantially reduced (p < 0.05) human (U937) cell lines binding to TNF-α activated human endothelial aortic cells. The assays involving the 32P-labelled NF-kB as a probe demonstrated that DHA pre-treatment decreased the shifted bands density following the stimulation of TNF-α. Nuclear extracts immune blot assessment and immune fluorescence staining showed a significant decrease (p < 0.05) in the NF-κB p65 concentration in the nuclei with DHA treated human endothelial aortic cells. Together these findings indicate that DHA inhibits nuclear trans localization of TNF-α-induced NF-κB p65, and thus considerably suppresses (p < 0.05) the VCAM-1 expression, which contributes to lower leukocyte adherence suggesting that DHA helps in preventing inflammatory atherosclerosis in vivo.

Keywords: ApoE−/−; atherosclerosis; dehydroabietic acid; TNF-α

Abstrak

Asid dehidroabietik (DHA) ialah analog asid abietik (AA) untuk pencegahan penyakit kardiovaskular yang diketahui bertindak secara farmakologi terhadap penuaan, keradangan, jangkitan bakteria dan kanser. Penyelidikan semasa mengkaji mekanisme molekul DHA pada kelekatan leukosit endotelium dan pengaktifan NF-κB dalam TNF-α yang dirawat HAEC dan ApoE-/- tikus dalam aterosklerosis uji kaji. HAEC telah diuji untuk ketoksikan menggunakan ujian MTT pada pelbagai kepekatan DHA. Pengekspresan permukaan sel CAM terhadap molekul lekatan leukosit endotelium-1, ICAM -1, atau VCAM-1 manusia ditentukan melalui ujian ELISA, diikuti oleh analisis pemblotan western. Ujian lekatan sel-leukosit endotelium yang melibatkan sel U937 telah dijalankan diikuti dengan penentuan pengekspresan NF-κB p65. ApoE−/− tikus diberi makan dengan diet kolesterol tinggi setiap hari diikuti dengan pemberian oral DHA (10 dan 20 mg/kg/hari). DHA (5 dan 10 mM) mengurangkan dengan ketara (p <0.05) garisan sel manusia (U937) yang mengikat kepada sel aorta endotelium manusia yang diaktifkan TNF-α. Ujian yang melibatkan NF-kB berlabel 32P sebagai prob menunjukkan bahawa pra-rawatan DHA mengurangkan ketumpatan jalur beralih berikutan rangsangan TNF-α. Ekstrak nuklear penilaian pemblotan imun dan pewarnaan pendarfluor imun menunjukkan penurunan ketara (p <0.05) dalam kepekatan NF-κB p65 dalam nukleus dengan sel aorta endotelium manusia yang dirawat DHA. Bersama-sama penemuan ini menunjukkan bahawa DHA menghalang penyetempatan trans nuklear NF-κB p65 yang disebabkan oleh TNF-α dan dengan itu menekan dengan ketara (p <0.05) pengekspresan VCAM-1, yang menyumbang kepada pematuhan leukosit yang lebih rendah yang menunjukkan bahawa DHA membantu dalam mencegah aterosklerosis radang secara in vivo.

Kata kunci: ApoE−/−; asid dehidroabietik; aterosklerosis; TNF-α

RUJUKAN

Ammirati, E., Moroni, F., Magnoni, M. & Camici, P.G. 2015. The role of T and B cells in human atherosclerosis and atherothrombosis. Clinical & Experimental Immunology 179(2): 173-187.

Chen, B., Li, J. & Zhu, H. 2016. AMP-activated protein kinase attenuates oxLDL uptake in macrophages through PP2A/NF-κB/LOX-1 pathway. Vascular Pharmacology 85: 1-10.

Fong, L.Y., Ng, C.T., Cheok, Z.L., Moklas, M.A.M., Hakim, M.N. & Ahmad, Z. 2016. Barrier protective effect of asiatic acid in TNF-α-induced activation of human aortic endothelial cells. Phytomedicine 23(2): 191-199.

Gal-Ben-Ari, S., Barrera, I., Ehrlich, M. & Rosenblum, K. 2019. PKR: A kinase to remember. Frontiers in Molecular Neuroscience 11: 480.

Gaul, S., Schaeffer, K.M., Opitz, L., Maeder, C., Kogel, A., Uhlmann, L., Kalwa, H., Wagner, U., Haas, J., Behzadi, A. & Pelegrin, P. 2021. Extracellular NLRP3 inflammasome particles are internalized by human coronary artery smooth muscle cells and induce pro-atherogenic effects. Scientific Reports 11(1): 15156.

Gonçalves, M.D., Bortoleti, B.T.S., Tomiotto-Pellissier, F., Miranda-Sapla, M.M., Assolini, J.P., Carloto, A.C.M., Carvalho, P.G.C., Tudisco, E.T., Urbano, A., Ambrósio, S.R. & Hirooka, E.Y. 2018. Dehydroabietic acid isolated from Pinus elliottii exerts in vitro antileishmanial action by pro-oxidant effect, inducing ROS production in promastigote and downregulating Nrf2/ferritin expression in amastigote forms of Leishmania amazonensis. Fitoterapia 128: 224-232.

Guo, R., Li, L., Su, J., Li, S., Duncan, S.E., Liu, Z. & Fan, G. 2020. Pharmacological activity and mechanism of Tanshinone IIA in related diseases. Drug Design, Development and Therapy 14: 4735-4748.

Hofmann, A., Brunssen, C., Poitz, D.M., Langbein, H., Strasser, R.H., Henle, T., Ravens, U. & Morawietz, H. 2017. Lectin-like oxidized low-density lipoprotein receptor-1 promotes endothelial dysfunction in LDL receptor knockout background. Atherosclerosis Supplements 30: 294-302.

Kato, R., Mori, C., Kitazato, K., Arata, S., Obama, T., Mori, M., Takahashi, K., Aiuchi, T., Takano, T. & Itabe, H. 2009. Transient increase in plasma oxidized LDL during the progression of atherosclerosis in apolipoprotein E knockout mice. Arteriosclerosis, Thrombosis, and Vascular Biology 29(1): 33-39.

Kim, E., Kang, Y.G., Kim, Y.J., Lee, T.R., Yoo, B.C., Jo, M., Kim, J.H., Kim, J.H., Kim, D. & Cho, J.Y. 2019. Dehydroabietic acid suppresses inflammatory response via suppression of Src-, Syk-, and TAK1-mediated pathways. International Journal of Molecular Sciences 20(7): 1-14.

Kim, J., Kang, Y.G., Lee, J.Y., Choi, D.H., Cho, Y.U., Shin, J.M., Park, J.S., Lee, J.H., Kim, W.G., Seo, D.B. & Lee, T.R. 2015. The natural phytochemical dehydroabietic acid is an anti-aging reagent that mediates the direct activation of SIRT1. Molecular and Cellular Endocrinology 412: 216-225.

Kleinholz, C.L., Riek-Burchardt, M., Seiß, E.A., Amore, J., Gintschel, P., Philipsen, L., Bousso, P., Relja, B., Schraven, B., Handschuh, J. & Mohr, J. 2021. Ly6G deficiency alters the dynamics of neutrophil recruitment and pathogen capture during Leishmania major skin infection. Scientific Reports 11: 15071.

Kumboyono, K., Nurwidyaningtyas, W., Chomsy, I.N. & Wihastuti, T.A. 2021. Early detection of negative smoking impacts: Vascular adaptation deviation based on quantification of circulated endothelial activation markers. Vascular Health and Risk Management 17: 103-109.

Li, D.C., Bao, X.Q., Sun, H. & Zhang, D. 2015. Research progress in the study of protective effect of tanshinone IIA on cerebral ischemic stroke. Yao Xue Xue Bao 50(6): 635-639.

Liu, Y.X., Yuan, P.Z., Wu, J.H. & Hu, B. 2021. Lipid accumulation and novel insight into vascular smooth muscle cells in atherosclerosis. Journal of Molecular Medicine 99(11): 1511-1526.

Liu, Z., Xu, S., Huang, X., Wang, J., Gao, S., Li, H., Zhou, C., Ye, J., Chen, S., Jin, Z.G. & Liu, P. 2015. Cryptotanshinone, an orally bioactive herbal compound from D anshen, attenuates atherosclerosis in apolipoprotein E‐deficient mice: Role of lectin‐like oxidized LDL receptor‐1 (LOX‐1). British Journal of Pharmacology 172(23): 5661-5675.

Luchnikova, N.A., Ivanova, K.M., Tarasova, E.V., Grishko, V.V. & Ivshina, I.B. 2019. Microbial conversion of toxic resin acids. Molecules 24(22): 1-18.

Luo, D., Ni, Q., Ji, A., Gu, W., Wu, J. & Jiang, C. 2016. Dehydroabietic acid derivative QC4 induces gastric cancer cell death via oncosis and apoptosis. BioMed Research International 2016: 2581061.

Malekmohammad, K., Sewell, R.D. & Rafieian-Kopaei, M. 2019. Antioxidants and atherosclerosis: Mechanistic aspects. Biomolecules 9(8): 1-19.

Moreti, D.L.C., Leandro, L.F., Moraes, T.D.S., Moreira, M.R., Veneziani, R.C.S., Ambrosio, S.R., Gomes, B.P.F.A. & Martins, C.H.G. 2017. Mikania glomerata Sprengel extract and its major compound ent-kaurenoic acid display activity against bacteria present in endodontic infections. Anaerobe 47: 201-208.

Poles, J., Karhu, E., McGill, M., McDaniel, H.R. & Lewis, J.E. 2021. The effects of twenty-four nutrients and phytonutrients on immune system function and inflammation: A narrative review. Journal of Clinical and Translational Research 7(3): 333-376.

Poursaleh, A., Beigee, F.S., Esfandiari, G. & Najafi, M. 2021. Adhesion of monocytes and endothelial cells isolated from the human aorta suppresses by miRNA-PEI particles. BMC Cardiovascular Disorders 21(1): 1-8.

Shah, A., Lindquist, J.A., Rosendahl, L., Schmitz, I. & Mertens, P.R. 2021. Novel insights into YB-1 signaling and cell death decisions. Cancers 13(13): 1-13.

Shimizu, I. & Minamino, T. 2020. Cellular senescence in arterial diseases. Journal of Lipid and Atherosclerosis 9(1): 79-91.

Singh, S. & Gautam, A.S. 2019. Upregulated LOX-1 receptor: Key player of the pathogenesis of atherosclerosis. Current Atherosclerosis Reports 21(10): 1-14.

Vinué, Á., Herrero-Cervera, A. & González-Navarro, H. 2018. Understanding the impact of dietary cholesterol on chronic metabolic diseases through studies in rodent models. Nutrients 10(7): 1-21.

Wang, X., Pang, F.H., Huang, L., Yang, X.P., Ma, X.L., Jiang, C.N., Li, F.Y. & Lei, F.H. 2018. Synthesis and biological evaluation of novel dehydroabietic acid-oxazolidinone hybrids for antitumor properties. International Journal of Molecular Sciences 19(10): 1-17.

Wolf, D. & Ley, K. 2019. Immunity and inflammation in atherosclerosis. Circulation Research 124(2): 315-327.

Zhang, H., Ge, S., He, K., Zhao, X., Wu, Y., Shao, Y. & Wu, X. 2019. FoxO1 inhibits autophagosome-lysosome fusion leading to endothelial autophagic-apoptosis in diabetes. Cardiovascular Research 115(14): 2008-2020.

Zhang, M., Xie, Y., Su, X., Liu, K., Zhang, Y., Pang, W. & Wang, J. 2019. Inonotus sanghuang polyphenols attenuate inflammatory response via modulating the crosstalk between macrophages and adipocytes. Frontiers in Immunology 10(286): 1-12.

^*Pengarang untuk surat-menyurat; email: tezhenwuyan@163.com